Second Sight Medical Products, Inc. Gains 54.32%

Second Sight Medical Products, Inc. (EYES:NASDAQ) jumped higher at $1.5, a gain of 54.3%. On Mon 30 Nov 20, EYES:NASDAQ hit a New 2-Week Intraday High of $1.1. The stock got featured on our News Catalysts scanner on Tue 10 Nov 20 at 08:34 AM in the 'RESUMPTION' category. From Mon 16 Nov 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed 25 Nov 20 at $1.27 with a volume of 6M+.
About Second Sight Medical Products, Inc. (EYES:NASDAQ)
Second Sight Medical Products Inc develops, manufactures and markets implantable prosthetic devices that can restore some functional vision to patients blinded by outer retinal degenerations, such as Retinitis Pigmentosa.
Top 10 Gainers:
- Auris Medical Holding Ltd. (EARS:NASDAQ), 371.17%
- STWO (STWO:NASDAQ), 100%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 54.32%
- TDH Holdings, Inc. (PETZ:NASDAQ), 53.79%
- Corporacion America Airports S.A. (CAAP:NYSE), 42.99%
- DIRTT Environmental Solutions Ltd. (DRTT:NASDAQ), 32.93%
- Arlo Technologies, Inc. (ARLO:NYSE), 31.18%
- Jaguar Health, Inc. (JAGX:NASDAQ), 30.89%
- CollPlant Biotechnologies Ltd. (CLGN:NASDAQ), 29%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 28.45%